Bio Medica Laboratories Ltd. (BMLL), incorporated in 2015, is a pharmaceutical manufacturing company based in Madhya Pradesh, focused on parenteral formulations. The company specialises in producing injectable drugs, including both liquid and dry powder injections, available in single-dose and multi-dose formats for human as well as veterinary use. BMLL operates on a B2B contra
| Investory Category | Subscription Percentage | Amount Raised (₹ Crores) |
|---|---|---|
| Qualified Institutional Buyers (QIBs) | 1% | 37,720 crores |
| Non-Institutional Investors (NIIs) | 48% | 18,10,560 crores |
| Retail Individual Investors (RIIs) | 51% | 19,23,720 crores |
Promoters bring 35+ years of combined pharma industry experience.
Diverse portfolio of 70+ injectable formulations across human and veterinary segments.
Certified manufacturing with GMP & GLP standards ensuring quality compliance.
In-house lab with advanced testing equipment supporting quality control.
| Allotment Date | Listing Date | Refund Date |
|---|---|---|
| 26 May '26 | -- | 27 May '26 |
| Issue Composition: | |
|---|---|
| Face Value | ₹10 per share |
| Total Issue Size | 37,72,000 shares (aggregating up to ₹2,78,000 crores) |
| Fresh Issue | 3,20,600 shares (aggregating up to ₹32,06,000 crores) |
| Offer for Sale | 37,700 shares of ₹10 (aggregating up to ₹3,77,000 crores) |
| Issue Type | Book building |
| Post-Issue Shareholding Pattern: | |
|---|---|
| Pre-Issue Shareholding | 96.84 shares |
| Post-Issue Shareholding | 67.69 shares |
| Minimum Lot Size | -- |
| Maximum Lot Size (Retail) | -- |
The lot size of Bio Medica Laboratories ipo has been designed to ensure broad participation while maintaining optimal price discovery.
Plot No 11 B-11 C Sector- E Sanwer Road Industrial Area Indore
Skyline Financial Services Pvt.Ltd.
| Book Running Lead Manager(s) |
|---|
| Narnolia Financial Services Ltd |